Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase

J Invest Dermatol. 2007 Apr;127(4):751-61. doi: 10.1038/sj.jid.5700683. Epub 2007 Jan 11.

Abstract

Tyrosinase, a copper-containing glycoprotein, is the rate-limiting enzyme critical for melanin biosynthesis in specialized organelles termed melanosomes that are produced only by melanocytic cells. Inhibitors of tyrosinase activity have long been sought as therapeutic means to treat cutaneous hyperpigmentary disorders. Multiple potential approaches exist that could control pigmentation via the regulation of tyrosinase activity, for example: the transcription of its messenger RNA, its maturation via glycosylation, its trafficking to melanosomes, as well as modulation of its catalytic activity and/or stability. However, relatively little attention has been paid to regulating pigmentation via the stability of tyrosinase, which depends on its processing and maturation in the endoplasmic reticulum and Golgi, its delivery to melanosomes and its degradation via the ubiquitin-proteasome pathway and/or the endosomal/lysosomal system. Recently, it has been shown that carbohydrate modification, molecular chaperone engagement, and ubiquitylation all play pivotal roles in regulating the degradation/stability of tyrosinase. While such processes affect virtually all proteins, such effects on tyrosinase have immediate and dramatic consequences on pigmentation. In this review, we classify melanogenic inhibitory factors in terms of their modulation of tyrosinase function and we summarize current understanding of how the quality control of tyrosinase processing impacts its stability and melanogenic activity.

Publication types

  • Review

MeSH terms

  • Animals
  • Catalysis
  • Enzyme Stability
  • Humans
  • Melanins / antagonists & inhibitors*
  • Melanins / biosynthesis*
  • Monophenol Monooxygenase / metabolism*
  • Protein Processing, Post-Translational
  • Time Factors

Substances

  • Melanins
  • Monophenol Monooxygenase